Next Article in Journal
Optimizing Nucleic Acid Extraction from Extended Bovine Semen for Endemic and High-Consequence Pathogens
Previous Article in Journal
Recent Advances in Nutritional Requirements and Metabolic Homeostasis Regulation of Animals Under Stress Conditions
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence and Antimicrobial Resistance Patterns of Salmonella in Asymptomatic Horses in Eastern Spain: A One Health Perspective

by
María Socorro Simó-Martínez
1,*,
Ana Marco-Fuertes
2,
Ángela Galán-Relaño
3,*,
Rafael J. Astorga Márquez
4,
Clara Marin
2,
Antonio Valero Díaz
5 and
Santiago Vega
2
1
Department of Animal Medicine and Surgery, Universidad Cardenal Herrera—CEU, CEU Universities, 46115 Valencia, Spain
2
Department of Animal Production and Health, Public Veterinary Health and Food Science and Technology, Faculty of Veterinary Medicine, Universidad Cardenal Herrera—CEU, CEU Universities, 46115 Valencia, Spain
3
Department of Nursing, Pharmacology and Physiotherapy Area, Faculty of Veterinary Medicine, University of Cordoba, 14014 Cordoba, Spain
4
Animal Health Department, Veterinary Faculty, University of Cordoba, 14014 Cordoba, Spain
5
Food Science and Technology Department, Veterinary Faculty, University of Cordoba, 14014 Cordoba, Spain
*
Authors to whom correspondence should be addressed.
Animals 2025, 15(23), 3413; https://doi.org/10.3390/ani15233413
Submission received: 22 October 2025 / Revised: 12 November 2025 / Accepted: 20 November 2025 / Published: 26 November 2025
(This article belongs to the Special Issue Tackling Salmonella Resistance in Animals)

Simple Summary

Horses can carry bacteria that may be harmful to both animals and humans, even when they show no signs of illness. One of these bacteria, Salmonella enterica, can spread through the environment and contribute to infections that are difficult to treat because of growing resistance to antibiotics. This study examined healthy horses in eastern Spain to find out how common this bacterium is and whether it shows resistance to antibiotics. Faecal samples from 95 horses were collected once daily over five consecutive days (475 samples in total), and Salmonella was detected in approximately one quarter of the animals. The most frequent types detected are known to cause disease in humans. Many of these bacterial strains were resistant to one or more antibiotics, and half were resistant to several at the same time. The study also found that poor hygiene and the storage of manure close to the animals were related to higher bacterial presence. These results show that healthy horses can act as silent carriers of bacteria that are important for public health. Monitoring them regularly and improving hygiene in equine facilities could help reduce the spread of antibiotic-resistant bacteria and protect both animal and human health.

Abstract

(1) Background: Salmonella are zoonotic pathogens, and rising antimicrobial resistance (AMR) amplifies their public health impact. Asymptomatic horses can act as reservoirs, contributing to environmental contamination and interspecies transmission. This study aimed to estimate the prevalence of Salmonella and characterize AMR patterns in healthy horses from eastern Spain. (2) Methods: Faecal samples from 95 asymptomatic horses were collected once daily over five consecutive days (475 samples in total) and processed under for Salmonella detection. Epidemiological information was obtained through owner questionnaires, and associations with Salmonella shedding were analyzed using generalized linear models. Antimicrobial susceptibility was assessed by minimum inhibitory concentration assays following the European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. (3) Results: Salmonella was detected in 25.3% of horses (24/95), with S. Enteritidis, S. Johannesburg, and S. Virchow as the most frequent serotypes. A significant association was observed between proximity of manure storage and bacterial detection (p < 0.001). Among 24 isolates of Salmonella, 88.9% were resistant to at least one antimicrobial, and 50% exhibited multidrug resistance. The highest resistance rates were against sulfamethoxazole and gentamicin, followed by ciprofloxacin and tigecycline. (4) Conclusions: Healthy horses can act as silent carriers of multidrug-resistant Salmonella, highlighting the need for surveillance, strengthened biosecurity, and prudent antimicrobial use within a One Health framework.

1. Introduction

Throughout history and the domestication process of animals, horses and humans have shared a close and enduring relationship. Initially, horses were primarily used as a means of transportation, labour, and food production. However, Spain’s equine industry, one of the oldest globally, has undergone significant transformation in recent decades, marked by a notable shift in its economic focus. The sector has progressively diversified from traditional functions toward activities related to leisure, sports, tourism or genetics improvement [1].
The close human-horse relationship and the shared environment create a potential risk of transmission of zoonotic diseases. Among these, salmonellosis of public health importance. In horses, Salmonella infection may be subclinical or manifest with clinical signs ranging from mild symptoms such as fever and dehydration to diarrhoea, colic, and manifestations of septicaemia [2,3,4,5]. Moreover, horses can act as reservoirs, shedding the bacterium into the environment and facilitating transmission to humans and other animals. In fact, Salmonella spp. is one of the leading pathogens causing foodborne infections in humans across Europe, with over 77,486 confirmed cases in 2023 [6]. It is estimated that approximately 150 million people worldwide become ill with non-typhoidal Salmonella (NTS) each year, resulting in around 60,000 deaths [7].
Equine salmonellosis may occur as sporadic cases or as outbreaks [8,9,10,11,12,13,14,15,16,17,18], including in veterinary hospitals, where mortality rates have reach up to 44% [8,9,10,12,14,19,20,21]. Hospitalization and antimicrobial therapy have been shown to increase horses’ susceptibility to Salmonella infection [19], particularly to serotypes shed by asymptomatic horses present in same facilities [5,14]. This underscores the importance of controlling environmental sources of contamination in equine settings.
Beyond this pathogenic potential, Salmonella spp. is one of the most critical pathogens according to the World Health Organization (WHO) due to its high levels of antimicrobial resistance (AMR) [22]. Consequently, horses may act not only as disseminators of this bacterium, but also as carriers of the AMR genes. Indeed, the WHO classifies AMR as one of the major challenges facing global public health, primarily due to the emergence of multidrug-resistant (MDR) strains, which complicate treatment and reduce therapeutic efficacy. Overall, both directly and indirectly, AMR causes 4.95 million deaths each year [22] making it imperative to evaluate and monitor AMR in this bacterium. One of the main reasons for the increasing rate of salmonellosis outbreaks is the presence of MDR strains of Salmonella [8,11,16,23,24], which complicate treatment and lead to therapeutic failures. Therefore, understanding the role of horses as potential disseminators of pathogens and AMR genes within shared environments is essential for developing effective prevention strategies under the One Health approach.
In this context, the main objective of the present study was to assess the prevalence of Salmonella spp. in asymptomatic horses and to evaluate the influence of external risk factors on its presence. Additionally, the antimicrobial resistance (AMR) and multidrug resistance (MDR) profiles of isolates recovered from horses in the Hoya de Buñol geographic area (Valencia Region, Spain) were characterized.

2. Materials and Methods

2.1. Experimental Design

To determine the prevalence of Salmonella spp. in asymptomatic horses, sampling was conducted in the Hoya de Buñol region, geographic area located within the Province of Valencia (Eastern Spain). This area was selected as a representative subset of the healthy equine population, given its demographic and territorial characteristics, which reflect those of the broader horse population in the Valencian Community. Since no previous studies had investigated the prevalence using a sampling protocol that accounted for the intermittent shedding of the bacterium, samples were obtained from a representative number of animals to ensure a reliable estimation of carrier status within the population.
The animal study was reviewed and approved by the Animal Ethics Committee at UCH-CEU University (code of research CEEA 22/05).
Written informed consent was obtained from all horse owners prior to sampling and data collection.

2.2. Epidemiological Data Collection

Along with sample collection, a structured questionnaire was completed by the horse owners, gathering general information about each animal as following: sex, age or breed, housing conditions, and lifestyle. Additional data collected through the epidemiological survey included pathology history, recent pharmacological treatments (e.g., antibiotics, anti-inflammatories, or other drugs) and horse’s primary activity, which was grouped into three major categories: leisure, sport, and breeding/reproduction. This questionnaire is provided in the Supplementary Materials (Supplementary Materials S1).
For statistical analysis, horses were classified by age into three categories: foals/young horses (0 to 5 years old), adults (6 to 18 years old) and geriatrics (>19 years old) [25,26,27,28].
Housing types were categorized as stall, paddock, or a combination of both. Information was compiled regarding the cleanliness of the facilities, including how often manure was cleaned and the distance of the manure storage from the animals. The cleaning frequency of the stalls/paddocks was categorized as daily, weekly, monthly/or less frequent. Additionally, the distance from the housing to the manure storage was considered and grouped into three categories: <10 m, 11–99 m, and >100 m.
The sampled horses resided in either riding schools or breeding farms, and included individuals housed in stalls, outdoor paddocks, or both. Horses living individually as well as those cohabiting with other horses were included in the study.

2.3. Sample Collection

In the absence of epidemiological studies on the prevalence of Salmonella in asymptomatic horses in Europe, an estimate of the prevalence was determined through the random sampling of 100 horses from a specific area, Hoya de Buñol, which has been determined to have a population size of 539 horses.
Prior to sampling, each horse underwent a clinical examination, and vital parameters were recorded to confirm the absence of fever or diarrhea. Faecal samples were collected from the rectal ampulla of each horse over five consecutive days, given the intermittent shedding of the bacterium.
All samples were transported under refrigeration at ≤4 °C to the Veterinary Sciences Faculty microbiology laboratory from the University CEU Cardenal Herrera. Microbiological analyses were performed on the same day as the sample collection.

2.4. Salmonella Isolation

For the isolation of Salmonella spp., all samples were processed in accordance with ISO 6579-1:2017 [29]. Briefly, faecal samples were pre-enriched in buffered peptone water (BPW; Scharlau®, Barcelona, Spain) at a ratio of 1:10 v/v and were then incubated at 37 ± 1 °C for 24 h. Subsequently, 0.1 mL of the pre-enriched culture was inoculated onto a Modified Rappaport Vassiliadis agar plate (MSRV; Marcy l’Etoile, France) and incubated at 41.5 ± 1 °C for 48 h. Positive MSRV plates were subsequently transferred to Xylose Lysine Deoxycholate agar (XLD, Scharlau®, Barcelona, Spain) and a selective chromogenic agar (ASAP; Marcy l’Étoile, France), followed by incubation at 37 ± 1 °C for 24–48 h.
Confirmed isolates were serotyped according to the Kauffmann–White scheme [30] at the National Reference Laboratory for Animal Health (Algete, Madrid, Spain) and stored at −80 °C for further analyses.

2.5. Antimicrobial Susceptibility Testing

Antimicrobial susceptibility tests were performed using the EU Surveillance Salmonella/E. coli EUVSEC3 Sensititre Plate (Thermo Scientific™Sensititre™, Madrid, Spain). This plate includes 15 antimicrobials of public health relevance and complies with the monitoring and reporting of antimicrobial resistance in zoonotic and commensal bacteria in food-producing animals, as outlined in Decision (EU) 2020/1729 [31].
The AMR was evaluated using the minimum Inhibitory concentration (MIC) assay with Thermo Scientific™ Sensititre™ Plates (Madrid, Spain) according to the manufacturer’s instructions. All results were interpreted based on the clinical breakpoints established by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) in 2024 [32]. The antimicrobials tested, and their corresponding concentration ranges are detailed in Supplementary Materials S2 (Table S1). Additionally, multidrug resistance (MDR) was defined as acquired resistance to at least one agent within three or more antibiotic classes [33].
For antimicrobial susceptibility testing, frozen Salmonella isolates were thawed and cultured on nutrient agar, followed by incubation at 37 ± 1 °C for 24 h. After incubation, individual colonies were suspended in 5 mL of sterile demineralized water (T3339; ThermoFisher Scientific™, Madrid, Spain). Each bacterial suspension was mixed and standardized to a density of 0.5 McFarland using a Nephelometer (ThermoFisher Scientific™, Madrid, Spain). Subsequently, 10 μL of the suspension were inoculated in a vial containing 11 mL of Mueller–Hinton broth (T3462; ThermoFisher Scientific™, Madrid, Spain) and mixed. From this mixture, 50 μL of the vial contents were transferred into each well of the Sensititre plate. The plates were then sealed with adhesive film and incubated at 37 ± 1 °C for 24 h. Manual reading of the plates was carried out using a Sensititre Vizion (Thermo Scientific™ Sensititre™ Vizion™ Digital MIC Viewing System, ThermoFisher Scientific, Madrid, Spain).

2.6. Statistical Analysis

A binomial generalized linear model (GLM) with a probit link was fitted to assess associations between Salmonella spp. carriage and the evaluated epidemiological risk factors (age, sex, medical history including prior pathologies and treatments, equine fitness level, recent travel, housing type, distance from the manure storage area, sanitation frequency, and direct interspecies contact). The same model structure was used to explore associations between these factors and AMR or MDR among Salmonella spp. isolates. Groupwise differences in proportions were further assessed using Pearson’s χ2 tests, with Fisher’s exact tests applied whenever any expected cell count was <5, to corroborate GLM findings. Statistical significance was set at α = 0.05 (two-tailed). Data are presented as estimated marginal means (EMMs) ± standard errors. Analyses were performed in R 4.4.2 (R Core Team, Vienna, Austria) using the emmeans, car, and multcompView packages.
Pairwise comparisons between factor levels were derived from estimated marginal means (emmeans) with Sidak adjustment for multiple testing; adjusted p-values and 95% confidence intervals are reported.

3. Results

3.1. Epidemiological Data

A total of 95 asymptomatic horses were sampled. Of the 100 equines initially earmarked for sampling, five had to be excluded from the study, as samples could not be obtained from them for five consecutive days.
From these 95 asymptomatic horses, 31.6% corresponded to geldings (30/95), 37.9% mares (36/95) and 30.5% stallions (29/95), age ranging from 3 months to 30 years. According to the epidemiological survey completed by the owners, 10.5% (10/95) of the horses had a recorded history of previous pathology, and some had recently received pharmacological treatments, including antibiotics, anti-inflammatory drugs, or other medications. Regarding their primary activity, 64.2% (61/95) were classified as leisure horses, 30.5% (29/95) as sport horses, and 5.3% (5/95) as breeding/reproductive animals.
All these demographic and clinical characteristics are represented in Figure 1.
Additional information collected through the surveys concerned housing conditions, sanitation practices, interspecies interactions, and animal mobility. Most horses were housed in stalls (41.1%), with 66.6% of these cleaned daily. However, for paddocks, cleaning was performed daily in only 33.7% of cases. Regarding the distance between the horse accommodations and the manure storage, it was obtained that 18.9% of the horses were housed less than 10 m from the storage, 58.9% were between 11 and 99 m, and the remaining 22.1% were more than 100 m away from the manure storage. Furthermore, 18.9% of the sampled equine population had recently travelled for various purposes, including competitions, excursions and fairs (Figure 2).

3.2. Salmonella Identification and Serotyping

In total, 95 asymptomatic horses over five consecutive days were sampled, resulting in 475 samples collected. Out of the 95 horses sampled, 24 resulted positives to Salmonella spp. (25.3%) in at least one sample, with a total of 39 positive samples. Most positives were isolated to a single day; however, intermittent or sustained shedding was also observed. Specifically, three horses tested positive on two consecutive days, five on two non-consecutive days, two on three consecutive days, and one on four of five days separated by a single negative day (Table 1).
All Salmonella isolates were identified as Salmonella enterica subsp. enterica (n = 39). Regarding serotyping, only one isolate from each horse was submitted for serotyping, resulting in a total of 24 strains analyzed. The main serotypes isolated were S. Enteritidis at 45.8% (11/24), followed by S. Johannesburg and S. Virchow both 12.5% (3/24). Additionally, S. Typhimurium monophasic Variant (mST) and S. Anatum were present at 8.3% (2/24) (Figure 3).

3.3. Epidemiological Surveys

Subsequently, a statistical analysis was performed using the variables gathered from the epidemiological surveys to explore potential correlations between these factors and the presence of Salmonella-positive animals. The results showed a significant correlation between recent pharmacological treatments and the detection of Salmonella (p < 0.001). Among the treated horses, the prevalence of the Salmonella was 0% (0/3), compared with 26.08% (24/92) observed in the untreated group. While a discernible difference is evident, it should be interpreted with caution due to the marked imbalance in group sizes. Moreover, none of the treated horses had received antibiotics; the administered drugs belonged exclusively to the non-steroidal anti-inflammatory drugs (NSAID) group (phenylbutazone, flunixin meglumine). This inherent limitation of the sample suggests that, while an association is suggested, further research is required to validate and confirm this finding. Such research should comprise a more balanced sample distribution (Table 2).
In addition, significant associations were also identified between Salmonella detection and manure storage and paddock cleaning frequency. Horses housed in facilities where manure was stored within 10 m showed a markedly higher prevalence of Salmonella (50%; 9/18) compared to 25.42% (15/59) when manure was housed 11 and 99 m away, and 0% (0/21) when housed at distances greater than 100 m away (p < 0.001). Pairwise comparisons revealed that animals located more than 100 m from the manure storage site differed significantly from those located 11–99 m and those within 10 m; whereas no significant difference was detected between the 11–99 m and <10 m groups. Likewise, paddock cleaning frequency was also significantly associated with bacterial detection (p < 0.001). The prevalence reached 100% (4/4) in facilities with weekly cleaning, compared with 18.18% (4/22) with monthly cleaning and 28.12% (9/32) with daily cleaning. Pairwise analysis indicated that animals housed in paddocks cleaned on a weekly basis differed significantly from those in paddocks cleaned daily or monthly, while no significant difference was found between the daily and monthly cleaning groups. These findings emphasize the critical role of environmental management practices, particularly waste storage, as key factors shaping the Salmonella circulation in equine facilities (Table 2).

3.4. Antimicrobial Susceptibility Profiles

Among the isolated strains, it was found that 88.9% (21/24) exhibited resistance to at least one of the 15 antimicrobials tested, with 50% (12/24) of these strains showing a MDR pattern.
The highest resistance rates among the Salmonella isolates were observed for sulfamethoxazole and gentamicin, with 70.8% (17/24) and 42.9% (10/24) of isolates showing resistance, respectively. These were followed by ciprofloxacin 25% (6/24) (Table 3).
The complete distribution of antimicrobial resistance percentages for all tested antibiotics is presented in Table 4.

4. Discussion

Salmonella is a zoonotic pathogen of significant importance in both veterinary and public health. While often asymptomatic in horses, its presence poses a potential risk for transmission to humans, particularly in equestrian environments with frequent human–animal interaction. Monitoring healthy equine populations is essential for understanding the epidemiological patterns of Salmonella, detecting emerging serotypes, and identifying antimicrobial resistance profiles. Horses may act as silent reservoirs, contributing to environmental contamination and cross-species transmission. Consequently, surveillance efforts—particularly in regions with high equine density—are vital for early detection and for guiding antimicrobial stewardship within a One Health framework.
There are currently no studies reporting the prevalence of Salmonella in horses in Europe. One study on the presence of Salmonella and Shiga toxin-producing E. coli in horse faeces was conducted in Germany, analyzing faecal samples from 400 horses. PCR analyses were performed to detect S. enterica, and no positive samples were found [34]. In contrast, studies from the United States have shown that the prevalence of Salmonella shedding in horses can vary considerably depending on health status, season, and geographical region. Among healthy horses in the general equine population, the shedding prevalence is estimated at 0.8% [35] whereas in hospitalized horses, reported values range from 0.5% to 7%, depending on whether animals were tested upon admission or during hospitalization, respectively [2,10,17,36,37,38,39,40].
Detecting Salmonella in horses can be a diagnostic challenge due to the intermittent nature of bacterial shedding and the low concentration in equine faeces [21]. Consequently, regardless of the analytical method selected for Salmonella spp. detection and its sensitivity, the probability of detection from a single sample remains low. Additionally, because Salmonella is shed intermittently, as mentioned above, multiple consecutive samples from the same animal are recommended to improve diagnostic accuracy [14,41]. In the present study of asymptomatic horses, faecal samples were collected for five consecutive days, which likely explains the relatively high prevalence observed (25.3%). Notably, several Salmonella-positive horses were only identified on the fourth or even the fifth day of sampling (Table 1), supporting the enhanced sensitivity of extended sampling protocols for identifying intermittent shedders. Current recommendations are to take 3 to 5 samples at intervals of 12 to 24 h [17,21,42]. When interpreted in parallel, the estimated diagnostic sensitivity increases from 44% for a single sample, 66% for two, 82% for three, and 97% for five [21,42]. These findings underscore the importance of rigorous sampling protocols to avoid underestimating the true prevalence of Salmonella in equine populations.
Thus, differences in prevalence reported in U.S. studies may be explained by the fact that only a single sample per horse was typically collected [10,35,38]. Additionally, the results can vary depending on the isolation protocol used, as studies in other species indicate that the sample size/weight affects the success of isolating this bacterium [41].
In the present study, no significant associations were observed between the clinical variables collected and the presence of Salmonella. However, other studies have identified risk factors for the development of salmonellosis in horses, including feed restrictions and dietary changes [10,12]. Moreover, it has been demonstrated that elevated stress levels increased the risk of infection. This is attributed, for example, to transport and heat-induced stress, which may promote bacterial shedding in carrier animals and facilitate infection in susceptible animals [12,13,43]. Furthermore, foals are particularly vulnerable to infection due to increased exposure, reduced immunocompetence, and an undeveloped mature gut microbiota [14]. Other risk factors associated with increased risk include antibiotic therapy [14,44], abdominal surgery, gastrointestinal disease, and colic episodes [14,38], as these conditions may disrupt the intestinal microbiota and facilitate pathogen colonization [45]. In contrast to earlier findings, none of the aforementioned factors seemed to be associated with Salmonella shedding in the present study. Only environmental variables related to the manure storage distance and paddock cleaning frequency were significantly associated with Salmonella detection. The positive association between a greater distance from the manure storage area and a lower likelihood of Salmonella shedding seems reasonable, as horses are susceptible to contact with contaminated faeces, which facilitates infection. Interestingly, no statistically significant association was observed with the frequency of stall cleaning, whereas paddock cleaning frequency did show a significant association. Pairwise comparisons indicated differences between the weekly cleaning group and both the daily and monthly cleaning groups, while no difference was observed between the latter two. However, this finding may mainly because of only four horses were housed in paddocks with weekly cleaning, and all of them tested positive, in contrast to the larger sample sizes in the daily and monthly groups, which yielded more variable results. Consequently, this apparent significance should be interpreted with caution, as the sample size was not statistically representative. A statistically significant correlation was also found among horses receiving medical treatment; however, given the very limited number of treated animals, this result must likewise be interpreted with caution.
Geographic region may also influence shedding patterns with higher prevalence rates reported in warmer and more humid regions of North America compared to cooler and drier regions [35]. The horses included in our study were in the interior region of the eastern Iberian Peninsula, which is characterized by a Mediterranean-continental climate. Summers are typically short, warm, and mostly clear, while winters are long, cold, windy, and partly cloudy, with generally dry conditions throughout the year. Average annual temperatures typically range from 3 °C to 31 °C and rarely drop below −2 °C or rise above 34 °C [46]. However, these conditions are progressively changing caused by climate evolution [47]. Sampling in the present study was conducted between February and July. This climatic context should be considered when interpreting the observed prevalence, as higher Salmonella shedding rates would be expected in more humid regions.
Salmonella enterica subsp. enterica (subspecies I) is the most prevalent subspecies, accounting for approximately 99% of Salmonella infections in humans and other warm-blooded animals [19,48]. Among the Salmonella serotypes isolated in this study, S. Enteritidis, S. Virchow, and monophasic S. Typhimurium were identified. These serotypes are highly pathogenic to humans [20] and are recognized as major contributors to severe clinical outcomes, thus representing a significant public health concern. Beyond their virulence, these serovars are of particular concern due to their high AMR [22].
S. Enteritidis is considered a priority serotype in epidemiological surveillance, as it is the leading cause of human and animal clinical salmonellosis worldwide [18].
Monophasic S. Typhimurium is classified as an emerging serovar due to its increasing AMR; and S. Virchow has been designated by WHO as a high priority serovar [30]. Other serotypes isolated in this study, such as S. Agona, S. Vejle, and S. Johannesburg, are typically associated with contaminated food or environmental sources. Among these, S. Agona is particularly noteworthy for its emerging AMR profile. Additionally, although detected less frequently, S. Salamae and S. Johannesburg have previously been isolated predominantly from reptiles, including snakes [49,50,51].
Regarding AMR, the Salmonella spp. isolates obtained in our study exhibited high overall resistance 88.9% (21/24) and MDR in 50% (12/24) against the antimicrobials tested. Previous studies investigating AMR in Salmonella spp. have primarily focused on clinically affected animals that had received antibiotic treatment [2,15,45,52,53,54,55]. The most frequent antimicrobials for salmonellosis treatment in horses are ceftiofur, enrofloxacin, and gentamicin [15]. The use of such antibiotics may promote bacterial persistence in the gastrointestinal tract, as these drugs can disrupt the normal gut microbiota, which typically competes with Salmonella for nutrients and contributes to pathogen exclusion in healthy animals [15,56]. However, in this study, the highest levels of resistance were observed against sulfamethoxazole and gentamicin, with 70.8% (17/24) and 42.9% (10/24) of isolates showing resistance, respectively. This resistance profile may be considered relatively favourable, as these antimicrobials are not among the first-line drugs commonly recommended for the treatment of equine salmonellosis. Nevertheless, the frequent use of some of these agents in equine practice raises concerns regarding the potential dissemination of resistance within equine populations. The epidemiological survey carried out in the present study also considered recent treatments of the animals, of which 3.2% had received treatment. Therefore, treatment-related intestinal dysbiosis cannot explain the observed high prevalence of Salmonella spp. or AMR profiles. The potential association between antimicrobial treatment and Salmonella shedding could not be assessed in this study, as the number of horses that had recently received antibiotic therapy was not representative. According to the owners, the few treated animals had only received NSAIDs in the short to medium term prior to sampling.
Antibiotic resistance is a major concern affecting both veterinary and human medicine. Although numerous studies highlight the increasing antimicrobial resistance of Salmonella spp., a longitudinal study conducted by Cummings et al. (2016) [2] examined the evolution of antimicrobial resistance in Salmonella spp. strains over 13 years confirming a decline in resistance. As noted previously, most of these studies were conducted on symptomatic animals that had received antibiotic treatment. Nevertheless, untreated animals can still exhibit resistance due to the transmission of multidrug-resistant organisms (MDROs) between individuals or even across species boundaries [52]. This phenomenon underscores the importance of addressing antimicrobial resistance from a One Health perspective, recognizing that humans, animals, and the environment serve as interconnected reservoirs and transmission pathways for resistant microorganisms.

5. Conclusions

The prevalence of Salmonella spp. in asymptomatic horses from eastern Spain was markedly higher than previously reported in other countries, with a detection rate of 25.3%. The isolates included zoonotic serotypes of major public health relevance, such as S. Enteritidis, S. Typhimurium monophasic, and S. Virchow, with 50% of the isolates displaying MDR profiles or phenotypes. These findings indicate that horses may serve not only as silent reservoirs of Salmonella spp. but also as potential vectors for the dissemination of this pathogen and its AMR genes in shared environments, particularly where close human–animal contact occurs.
From a One Health approach, these results underscore the urgent need to implement targeted surveillance programs in equine populations, even in the absence of clinical signs, and to reinforce biosecurity protocols and antimicrobial stewardship in equine practice. Furthermore, multicenter and longitudinal studies are required to monitor temporal trends, assess geographic variability, and identify management-related risk factors, thereby advancing our understanding of the role of healthy horses in the epidemiology of Salmonella and the broader AMR landscape.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ani15233413/s1, Supplementary Materials S1: Field Questionnaire and Informed Consent Form for the Study of Salmonella spp. in Asymptomatic Horses. Supplementary Materials S2: Table S1. Antimicobials included on the EUVSEC3 Sensititre plate for EU surveillance of Salmonella/E. coli (Thermo Scientific™ Sensititre™, Madrid, Spain), showing the concentration ranges assessed and the WHO classification. These agents are recognised as of public-health importance in Decision (EU) 2020/1729.

Author Contributions

Conceptualization, S.V., C.M. and M.S.S.-M.; methodology, S.V., C.M., A.M.-F. and M.S.S.-M.; software, A.M.-F. and M.S.S.-M.; validation, A.M.-F., S.V. and M.S.S.-M.; formal analysis, M.S.S.-M.; investigation, M.S.S.-M. and A.M.-F.; resources, M.S.S.-M. and C.M.; data curation, M.S.S.-M.; writing—original draft preparation, M.S.S.-M.; writing—review and editing, A.M.-F., Á.G.-R., R.J.A.M., A.V.D. and M.S.S.-M.; visualization, M.S.S.-M.; supervision, Á.G.-R., S.V. and R.J.A.M.; project administration, S.V. and R.J.A.M.; funding acquisition, S.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The animal study protocol was approved by the Animal. Ethics Committees of UNIVERSIDAD CARDENAL HERRERA-CEU (code of research CEEA 22/05).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Acknowledgments

The authors wish to express their sincere gratitude to the field veterinarians who kindly facilitated contact with the riding schools and stud farms for sample collection from their clients’ horses, especially Lydia Del Barrio (Equiclinic Veterinarios), Lorenzo Chover (Integral Equina), Guillermo Arnal, and Álvaro Cervera. The authors are also deeply grateful to the horse owners for their voluntary participation in this study. Special thanks are extended to the team at the Consorcio Hospital General Universitario de Valencia, where part of the analyses were performed. The authors also wish to thank the collaborating students and farm scholarship holders—Romane Kirsch, Mathilde Clert, Aurora Querol, and Laura Sala—for their valuable assistance in different parts of the project.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
AMIAmikacin
AMRAntimicrobial Resistance
AMPAmpicillin
ASAPAdvanced Software for Analysis of Patterns
AZIAzithromycin
BPWBuffered Peptone Water
CEUCardenal Herrera CEU University
CHLChloramphenicol
CIPCiprofloxacin
CIACritically Important Antimicrobial
COLColistin
CTACefotaxime
CTZCeftazidime
EUCASTEuropean Committee on Antimicrobial Susceptibility Testing
EUVSEC3European Union Surveillance Sensititre Plate for Salmonella/E. coli
FQFluoroquinolone
GENGentamicin
GLMGeneralized Linear Model
HIAHighly Important Antimicrobial
HPCIAHighest Priority Critically Important Antimicrobial
ISOInternational Organization for Standardization
MDRMultidrug Resistance
MERMeropenem
MICMinimum Inhibitory Concentration
MRSAMethicillin-Resistant Staphylococcus aureus
MSRVModified Rappaport Vassiliadis Agar
NALNalidixic Acid
NSAIDNon-Steroidal Anti-Inflammatory Drug
NTSNon-Typhoidal Salmonella
PCRPolymerase Chain Reaction
PRANNational Antimicrobial Resistance Plan (Spain)
RStatistical Software “R”
SDStandard Deviation
SMESulfamethoxazole
S.Salmonella
TIGTigecycline
TETTetracycline
TRITrimethoprim
UCH-CEUUniversidad Cardenal Herrera-CEU
UELNUniversal Equine Life Number
WHOWorld Health Organization
XLDXylose Lysine Deoxycholate Agar

References

  1. Ministerio de Agricultura Pesca y Alimentación. G de España. SECTOR EQUINO EN CIFRAS. 2024. Available online: https://www.mapa.gob.es/dam/mapa/contenido/ganaderia/temas/produccion-y-mercados-ganaderos/sectores-ganaderos-2/equino/informacion-del-sector/indicadores-economicos/indicadores-economicos-equidos-2024.pdf (accessed on 19 November 2025).
  2. Cummings, K.J.; Perkins, G.A.; Khatibzadeh, S.M.; Warnick, L.D.; Aprea, V.A.; Altier, C. Antimicrobial resistance trends among Salmonella isolates obtained from horses in the northeastern United States (2001–2013). Am. J. Vet Res. 2016, 77, 505–513. [Google Scholar] [CrossRef]
  3. Hernandez, J.A.; Long, M.T.; Traub-Dargatz, J.L.; Besser, T.E. Salmonellosis. In Equine Infectious Diseases, 2nd ed.; Elsevier: Amsterdam, The Netherlands, 2014; pp. 321–333.e4. [Google Scholar]
  4. Dor, Z.; Shnaiderman-Torban, A.; Kondratyeva, K.; Davidovich-Cohen, M.; Rokney, A.; Steinman, A.; Navon-Venezia, S. Emergence and Spread of Different ESBL-Producing Salmonella enterica Serovars in Hospitalized Horses Sharing a Highly Transferable IncM2 CTX-M-3-Encoding Plasmid. Front. Microbiol. 2020, 11, 616032. [Google Scholar] [CrossRef]
  5. Barrow, P.A.; Methner, U. Salmonella in Domestic Animals, 2nd ed.; CABI: Oxfordshire, UK, 2013; pp. 305–317. Available online: https://vetbooks.ir/Salmonella-in-domestic-animals-2nd-edition/ (accessed on 19 November 2025).
  6. European Food Safety Authority (EFSA); European Centre for Disease Prevention and Control (ECDC). The European Union One Health 2023 Zoonoses report. EFSA J. 2024, 22, e9106. [Google Scholar] [CrossRef]
  7. Yellow Book|Yellow Book|CDC. 2025. Available online: https://www.cdc.gov/yellow-book/index.html (accessed on 19 November 2025).
  8. Dallap Schaer, B.L.; Aceto, H.; Rankin, S.C. Outbreak of Salmonellosis Caused by Salmonella enterica Serovar Newport MDR-AmpC in a Large Animal Veterinary Teaching Hospital. J. Vet. Intern. Med. 2010, 24, 1138–1146. [Google Scholar] [CrossRef]
  9. Bustos, C.P.; Dominguez, J.E.; Garda, D.; Moroni, M.; Pallarols Molinari, N.; Herrera, M.; Chacana, P.A.; Mesplet, M. Multiresistant and blaCTX-M-14-Carrying Salmonella ser. Typhimurium Isolated During a Salmonellosis Outbreak in an Equine Hospital in Argentina. J. Equine Vet. Sci. 2021, 99, 103404. [Google Scholar] [CrossRef]
  10. Traub-Dargatz, J.L.; Salman, M.D.; Jones, R.L. Epidemiologic study of Salmonellae shedding in the feces of horses and potential risk factors for development of the infection in hospitalized horses. J. Am. Vet. Med. Assoc. 1990, 196, 1617–1622. [Google Scholar] [CrossRef] [PubMed]
  11. Dargatz, D.A.; Traub-Dargatz, J.L. Multidrug-resistant Salmonella and nosocomial infections. Vet. Clin. N. Am. Equine Pract. 2004, 20, 587–600. [Google Scholar] [CrossRef] [PubMed]
  12. House, J.K.; Mainar-Jaime, R.C.; Smith, B.P.; House, A.M.; Kamiya, D.Y. Risk factors for nosocomial Salmonella infection among hospitalized horses. J. Am. Vet. Med. Assoc. 1999, 214, 1511–1516. [Google Scholar] [CrossRef] [PubMed]
  13. Kim, L.; Morley, P.S.; Traub-Dargatz, J.L.; Salman, M.D.; Gentry-Weeks, C. Factors associated with Salmonella shedding among equine colic patients at a veterinary teaching hospital. J. Am. Vet. Med. Assoc. 2001, 218, 740–748. [Google Scholar] [CrossRef]
  14. Ernst, N.S.; Hernandez, J.A.; MacKay, R.J.; Brown, M.P.; Gaskin, J.M.; Nguyen, A.D.; Giguere, S.; Colahan, P.T.; Troedsson, M.R.; Haines, G.R.; et al. Risk factors associated with fecal Salmonella shedding among hospitalized horses with signs of gastrointestinal tract disease. J. Am. Vet. Med. Assoc. 2004, 225, 275–281. [Google Scholar] [CrossRef]
  15. Leon, I.M.; Lawhon, S.D.; Norman, K.N.; Threadgill, D.S.; Ohta, N.; Vinasco, J.; Scott, H.M. Serotype diversity and antimicrobial resistance among Salmonella enterica isolates from patients at an equine referral hospital. Appl. Environ. Microbiol. 2018, 84, e02829-17. [Google Scholar] [CrossRef]
  16. Wright, J.G.; Tengelsen, L.A.; Smith, K.E.; Bender, J.B.; Frank, R.K.; Grendon, J.H.; Rice, D.H.; Thiessen, A.M.B.; Gilbertson, C.J.; Sivapalasingam, S.; et al. Multidrug-resistant Salmonella Typhimurium in Four Animal Facilities. Emerg. Infect. Dis. 2005, 11, 1235–1241. [Google Scholar] [CrossRef] [PubMed]
  17. Burgess, B.A.; Morley, P.S. Risk factors for shedding of Salmonella enterica among hospitalized large animals over a 10-year period in a veterinary teaching hospital. J. Vet. Intern. Med. 2019, 33, 2239–2248. [Google Scholar] [CrossRef]
  18. Astorga, R.; Arenas, A.; Tarradas, C.; Mozos, E.; Zafra, R.; Pérez, J. Outbreak of peracute septicaemic salmonellosis in horses associated with concurrent Salmonella enteritidis and Mucor species infection. Vet. Rec. 2004, 155, 240–242. [Google Scholar] [CrossRef] [PubMed]
  19. Bhat, K.A.; Manzoor, T.; Dar, M.A.; Farooq, A.; Allie, K.A.; Wani, S.M.; Dar, T.A.; Shah, A.A. Salmonella Infection and Pathogenesis. In Enterobacteria; IntechOpen: London, UK, 2022; Available online: https://www.intechopen.com/chapters/80044 (accessed on 19 November 2025).
  20. Crump, J.A.; Wain, J. Salmonella. Int. Encycl. Public Health 2017, 2, 425–433. [Google Scholar] [CrossRef]
  21. Burgess, B.A. Salmonella in Horses. Vet. Clin. N. Am. Equine Pract. 2023, 39, 25–35. [Google Scholar] [CrossRef] [PubMed]
  22. World Health Organization (WHO). Antimicrobial Resistance. 2024. Available online: https://www.who.int/news/item/17-05-2024-who-updates-list-of-drug-resistant-bacteria-most-threatening-to-human-health (accessed on 19 November 2025).
  23. Johnson, J.A. Nosocomial infections. Vet. Clin. N. Am. Small Anim. Pract. 2002, 32, 1101–1126. [Google Scholar] [CrossRef]
  24. Soza-Ossandón, P.; Rivera, D.; Tardone, R.; Riquelme-Neira, R.; García, P.; Hamilton-West, C.; Adell, A.D.; González-Rocha, G.; Moreno-Switt, A.I. Widespread Environmental Presence of Multidrug-Resistant Salmonella in an Equine Veterinary Hospital That Received Local and International Horses. Front. Vet. Sci. 2020, 7, 537557. [Google Scholar] [CrossRef]
  25. Mcgowan, C. Welfare of Aged Horses. Animals 2011, 1, 366–376. [Google Scholar] [CrossRef]
  26. Gómez-Arrones Egido, V. Cuidados del Caballo Geriátrico. 2023. Available online: https://www.diarioveterinario.com/t/4290842/cuidados-caballo-geriatrico-equino#:~:text=Hoy%20en%20d%C3%ADa%20se%20considera,o%20senior%20m%C3%A1s%20de%2020 (accessed on 19 November 2025).
  27. Plana, M.; Farriols, M.M. El Potro y las Etapas de su Desarrollo. 2020. Available online: https://www.ecuestre.es/app/blogs/doma-educativa-y-equitacion-conectada/el-potro-y-las-etapas-de-su-desarrollo (accessed on 19 November 2025).
  28. Lowther, A. Skeletal Maturity in Horses: Growth Plate Ossification and Age Considerations. 2023. Available online: https://www.horsesinsideout.com/post/skeletal-maturity-in-horses-growth-plate-ossification-and-age-considerations (accessed on 19 November 2025).
  29. ISO 6579-1:2017; Microbiology of the Food Chain—Horizontal Method for the Detection, Enumeration and Serotyping of Salmonella—Part 1: Detection of Salmonella spp. ISO: Geneva, Switzerland, 2017.
  30. Grimont, P.A.D.; Weill, F.X. WHO Collaborating Centre for Reference and Research on Salmonella. In Antigenic Formulae of the Salmonella serovars, 9th ed.; WHO: Geneva, Switzerland, 2007. [Google Scholar]
  31. European Food Safety Authority (EFSA); European Centre for Disease Prevention and Control (ECDC). The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2020/2021. EFSA J. 2023, 21, e07867. [Google Scholar] [CrossRef]
  32. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 15.0. 2025. Available online: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_15.0_Breakpoint_Tables.pdf (accessed on 19 November 2025).
  33. Magiorakos, A.P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012, 18, 268–281. [Google Scholar] [CrossRef]
  34. Pichner, R.; Sander, A.; Steinrück, H.; Gareis, M. Occurrence of Salmonella spp. and shigatoxin-producing Escherichia coli (STEC) in horse faeces and horse meat products. Berl. Munch. Tierarztl. Wochenschr. 2005, 118, 321–325. [Google Scholar] [PubMed]
  35. Traub-Dargatz, J.L.; Garber, L.P.; Fedorka-Cray, P.J.; Ladely, S.; Ferris, K.E. Fecal shedding of Salmonella spp. by horses in the United States during 1998 and 1999 and detection of Salmonella spp. in grain and concentrate sources on equine operations. J. Am. Vet. Med. Assoc. 2000, 217, 226–230. [Google Scholar] [CrossRef]
  36. Alinovi, C.A.; Ward, M.P.; Couëtil, L.L.; Wu, C.C. Risk factors for fecal shedding of Salmonella from horses in a veterinary teaching hospital. Prev. Vet. Med. 2003, 60, 307–317. [Google Scholar] [CrossRef]
  37. Uzal, F.A.; Arroyo, L.G.; Navarro, M.A.; Gomez, D.E.; Asín, J.; Henderson, E. Bacterial and viral enterocolitis in horses: A review. J. Vet. Diagn. Investig. 2022, 34, 354–375. [Google Scholar] [CrossRef]
  38. Smith, B.P.; Reina-Guerra, M.; Hardy, A.J. Prevalence and epizootiology of equine salmonellosis. J. Am. Vet. Med. Assoc. 1978, 172, 353–356. [Google Scholar] [CrossRef]
  39. Pusterla, N.; Byrne, B.A.; Hodzic, E.; Mapes, S.; Jang, S.S.; Magdesian, K.G. Use of quantitative real-time PCR for the detection of Salmonella spp. in fecal samples from horses at a veterinary teaching hospital. Vet. J. 2010, 186, 252–255. [Google Scholar] [CrossRef]
  40. Roberts, M.C.; O’boyle, D.A. The prevalence and epizootiology of salmonellosis among groups of horses in south east Queensland. Aust. Vet. J. 1981, 57, 27–35. [Google Scholar] [CrossRef] [PubMed]
  41. Funk, J.A.; Davies, P.R.; Nichols, M.A. The Effect of Fecal Sample Weight on Detection of Salmonella enterica in Swine Feces. J. Vet. Diagn. Investig. 2000, 12, 412–418. [Google Scholar] [CrossRef] [PubMed]
  42. Burgess, B.A.; Morley, P.S. Managing Salmonella in Equine Populations. Vet. Clin. N. Am. Equine Pract. 2014, 30, 623–640. [Google Scholar] [CrossRef]
  43. Owen, R.A.; Fullerton, J.; Barnum, D.A. Effects of transportation, surgery, and antibiotic therapy in ponies infected with Salmonella. Am. J. Vet. Res. 1983, 44, 46–50. [Google Scholar] [CrossRef]
  44. Hird, D.W.; Casebolt, D.B.; Carter, J.D.; Pappaioanou, M.; Hjerpe, C.A. Risk factors for salmonellosis in hospitalized horses. J. Am. Vet. Med. Assoc. 1986, 188, 173–177. [Google Scholar] [CrossRef]
  45. Bernard, W.V.; Sebastian, M.; Hemming, B. Salmonella Antimicrobial Activity of Selected Strains of Enterolactobacillus Species Isolated from the Gastrointestinal Tract of the Horse. J. Equine Vet. Sci. 2011, 31, 396–399. [Google Scholar] [CrossRef]
  46. Hermosilla, J.; Joan, P.; Membrado-Tena, C.; Aparicio, J.V.; Fansa, G.; Antequera, M. Estudios Comarcales de la Provincia de Valencia/Estudis Comarcals de la Província de València. Dirección y Coordinación Técnica/Direcció i Coordinació Tècnica Equipo Técnico/Equip Tècnic: ESTEPA Cartografía/Cartografia. 2018. Available online: https://datos.divaladl.es/userfiles/1078/Documentos/930e90368dEC_bunyol_OK.pdf (accessed on 19 November 2025).
  47. National Oceanic and Atmospheric Administration (NOAA). Climate change impacts|National Oceanic and Atmospheric Administration. 2025. Available online: https://www.noaa.gov/education/resource-collections/climate/climate-change-impacts (accessed on 19 November 2025).
  48. Brenner, F.W.; Villar, R.G.; Angulo, F.J.; Tauxe, R.; Swaminathan, B. Salmonella Nomenclature. J. Clin. Microbiol. 2000, 38, 2465–2467. [Google Scholar] [CrossRef] [PubMed]
  49. Pulford, C.V.; Wenner, N.; Redway, M.L.; Rodwell, E.V.; Webster, H.J.; Escudero, R.; Kröger, C.; Canals, R.; Rowe, W.; Lopez, J.; et al. The diversity, evolution and ecology of Salmonella in venomous snakes. PLoS Negl. Trop. Dis. 2019, 13, e0007169. [Google Scholar] [CrossRef]
  50. Mlangeni, L.N.; Ramatla, T.; Lekota, K.E.; Price, C.; Thekisoe, O.; Weldon, C. Occurrence, Antimicrobial Resistance, and Virulence Profiles of Salmonella Serovars Isolated from Wild Reptiles in South Africa. Int. J. Microbiol. 2024, 2024, 5213895. [Google Scholar] [CrossRef] [PubMed]
  51. Santana-Hernández, K.M.; Rodríguez-Ponce, E.; Medina, I.R.; Acosta-Hernández, B.; Priestnall, S.L.; Vega, S.; Marin, C.; Cerdà-Cuéllar, M.; Marco-Fuertes, A.; Ayats, T.; et al. One Health Approach: Invasive California Kingsnake (Lampropeltis californiae) as an Important Source of Antimicrobial Drug-Resistant Salmonella Clones on Gran Canaria Island. Animals 2023, 13, 1790. [Google Scholar] [CrossRef] [PubMed]
  52. Kaspar, U.; von Lützau, K.; Schlattmann, A.; Rösler, U.; Köck, R.; Becker, K. Zoonotic multidrug-resistant microorganisms among non-hospitalized horses from Germany. One Health 2019, 7, 100091. [Google Scholar] [CrossRef]
  53. Kohnen, A.B.; Wiedenheft, A.M.; Traub-Dargatz, J.L.; Short, D.M.; Cook, K.L.; Lantz, K.; Morningstar-Shaw, B.; Lawrence, J.P.; House, S.; Marshall, K.L.; et al. Antimicrobial susceptibility of Salmonella and Escherichia coli from equids sampled in the NAHMS 2015–16 equine study and association of management factors with resistance. Prev. Vet. Med. 2023, 213, 105857. [Google Scholar] [CrossRef]
  54. Chipangura, J.K.; Chetty, T.; Kgoete, M.; Naidoo, V. Prevalence of antimicrobial resistance from bacterial culture and susceptibility records from horse samples in South Africa. Prev. Vet. Med. 2017, 148, 37–43. [Google Scholar] [CrossRef]
  55. Haq, I.; Durrani, A.Z.; Khan, M.S.; Mushtaq, M.H.; Ahmad, I. Study of antimicrobial resistance and physiological biomarkers with special reference to Salmonellosis in diarrheic foals in Punjab, Pakistan. Acta Trop. 2017, 176, 144–149. [Google Scholar] [CrossRef] [PubMed]
  56. Feary, D.J.; Hassel, D.M. Enteritis and Colitis in Horses. Vet. Clin. N. Am. Equine Pract. 2006, 22, 437–479. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Demographic and clinical characteristics of the 95 asymptomatic horses included in the study. (a) Sex distribution, (b) Age classification, (c) History of pathology, (d) Recent pharmacological treatments, and (e) Main activity of the horses.
Figure 1. Demographic and clinical characteristics of the 95 asymptomatic horses included in the study. (a) Sex distribution, (b) Age classification, (c) History of pathology, (d) Recent pharmacological treatments, and (e) Main activity of the horses.
Animals 15 03413 g001
Figure 2. Management and environmental characteristics of the sampled equine population. (a) Distribution of housing systems among horses, categorized as stalls, paddocks, or a combination of both. (b) Cleaning frequency of housing facilities, represented as a percentage of horses living under each system. (c) Distance between horse accommodations and manure storage sites. (d) Proportion of horses with regular interspecies interaction, including contact with conspecifics, other domestic animals, or wildlife. (e) Percentage of horses that had recently travelled for purposes such as competitions, fairs, or excursions. These variables are relevant as potential risk factors for the presence and spread of antimicrobial-resistant Salmonella.
Figure 2. Management and environmental characteristics of the sampled equine population. (a) Distribution of housing systems among horses, categorized as stalls, paddocks, or a combination of both. (b) Cleaning frequency of housing facilities, represented as a percentage of horses living under each system. (c) Distance between horse accommodations and manure storage sites. (d) Proportion of horses with regular interspecies interaction, including contact with conspecifics, other domestic animals, or wildlife. (e) Percentage of horses that had recently travelled for purposes such as competitions, fairs, or excursions. These variables are relevant as potential risk factors for the presence and spread of antimicrobial-resistant Salmonella.
Animals 15 03413 g002
Figure 3. Graphical representation of the serotyping results for Salmonella spp. isolated from equine faecal samples.
Figure 3. Graphical representation of the serotyping results for Salmonella spp. isolated from equine faecal samples.
Animals 15 03413 g003
Table 1. Temporal distribution of Salmonella-positive results over five consecutive days. The table includes horses with ≥1 positive sample (n = 24/95). “+”, positive culture; blank, negative. Total positives samples = 39; consecutive positives: 3 horses (2 days) and 2 horses (3 days); one horse positive on 4/5 days with an intervening negative.
Table 1. Temporal distribution of Salmonella-positive results over five consecutive days. The table includes horses with ≥1 positive sample (n = 24/95). “+”, positive culture; blank, negative. Total positives samples = 39; consecutive positives: 3 horses (2 days) and 2 horses (3 days); one horse positive on 4/5 days with an intervening negative.
POSITIVE HORSEDAY 1DAY 2DAY 3DAY 4DAY 5
1+
2 ++
3 ++
4+
5++ ++
6+
7 +
8 +
9 +
10 +
11+ +
12 ++
13+ +
14 +++
15 + +
16 +
17 + +
18 + +
19 +
20 +
21 +++
22 +
23 +
24 +
Table 2. Association between epidemiological variables (sex, age, use, housing conditions, etc.) and positive Salmonella cultures.
Table 2. Association between epidemiological variables (sex, age, use, housing conditions, etc.) and positive Salmonella cultures.
Epidemiological DataClassification in Each GroupN of Animals per Group% of Animals Positive to Salmonellap-Value
AgeYoung18/9538.88 (7/18)0.170
Adult55/9518.18 (10/55)
Geriatric22/9531.81 (7/22)
SexGelding30/9523.3 (7/30)0.309
Male29/9517.24 (5/29)
Female36/9533.33 (12/36)
Pathology historyYes10/9520 (2/10)0.663
No85/9525 (22/85)
Recent pharmacological
treatments
Yes3/950 (0/3)<0.001
No92/9526.08 (24/92)
Horse activityReproduction5/9560 (3/5)0.237
Leisure61/9524.5 (15/61)
Sport29/9520.68 (6/29)
Recent travelYes18/9522.22 (4/18)0.733
No77/9525.97 (20/77)
Horse facilityBox39/9517.95 (7/39)0.2
Paddock33/9536.36 (12/33)
Both23/9521.73 (5/23)
Manure storage<10 m18/9550 (9/18)<0.001 *
11–99 m59/9525.42 (15/59)
>100 m21/950 (0)
Box cleaning frequencyMonthly0/950 (0)<0.123
Weekly22/9528.57 (8/22)
Daily44/9518.18 (8/44)
Paddock cleaning frequencyMonthly22/9518.18 (4/22)<0.001 *
Weekly4/95100 (4/4)
Daily32/9528.12 (9/32)
Contact with other horses and/or animals of other speciesYes95/952.4 (24/95)
No0/950 (0)
Chi-square test was used for categorical variables; p < 0.05 was considered significant. N = total animals sampled. * Pairwise comparisons: For manure storage, animals > 100 m differed significantly from those at 11–99 m and <10 m, with no difference between the latter two groups. For paddock cleaning frequency, weekly cleaning differed significantly from daily and monthly, with no difference between daily and monthly.
Table 3. Proportion of antimicrobial resistance (AMR) observed (by group and by individual antibiotic).
Table 3. Proportion of antimicrobial resistance (AMR) observed (by group and by individual antibiotic).
Antibiotic GroupAntibiotic% AMR
Folate-pathway inhibitorsSulfamethoxazole70.8 d ± 10.96
Trimethoprim4.2 ab ± 6.88
PolymyxinsColistin16.7 ab ± 6.88
QuinolonesNalidixic acid16.7 ab ± 12.07
Ciprofloxacin25 c ± 12.80
TetracyclinesTetracycline8.3 abc ± 9.35
GlycylcyclinesTigecycline16.7 ab ± 12.8
CarbapenemsMeropenem0 a ± 0
CephalosporinsCeftazidime0 a ± 0
Cefotaxime
PenicillinsAmpicillin4.2 ab ± 6.88
MacrolidesAzithromycin0 a ± 0
AmphenicolsChloramphenicol8.3 ab ± 6.88
AminoglycosidesGentamicin42.9 c ± 13.22
Amikacin
a–d: different superscript letters within each column denote statistically significant differences (p ≤ 0.05) in resistance levels among the antibiotics tested. ±: standard error of the mean.
Table 4. Antimicrobial resistance by serotype among Salmonella isolates.
Table 4. Antimicrobial resistance by serotype among Salmonella isolates.
SerotypenFolate-Pathway InhibitorsPolimixinsQuinolones
SulfamethoxazoleTrimetoprimColistin1st Generation2nd Generation
Nalidixic AcidCiprofloxacin
S. Enteritidis11/244/11 (36.3%) 1/11 (9.09%)
S. Johannesburg3/243/3 (100%) 2/3 (66.75%) 1/3 (33.3%)
S. Virchow3/243/3 (100%) 2/3 (66.7%)3/3 (100%)
S. Typhimurium monofasic2/242/2 (100%) 2/2 (100%) 1/2 (50%)
S. Anatum2/241/2 (50%)
S. Vejle1/241/1 (100%)
S. Salamae1/241/1 (100%)
S. Agona1/241/1 (100%)1/1 (100%) 1/1 (100%)1/1 (100%)
SerotypenTetracyclinesGlycylcyclinesCarbapenemsCephalosporinsPenicillins
TetracyclineTigecyclineMeropenemCefotaximeAmpicillin
Ceftazidime
S. Enteritidis11/241/11 (9.09%)1/11 (9.09%)
S. Johannesburg3/24
S. Virchow3/24 3/3 (100%) 1/3 (33.3%)
S. Typhimurium monofasic2/24
S. Anatum2/24
S. Vejle1/24
S. Salamae1/24
S. Agona1/241/1 (100%)1/1 (100%)
SerotypenMacrolidesAmphenicolsAminoglycosides 
AzithromycinChloramphenicolGentamicinAmikacin 
 
 
S. Enteritidis11/24 1/11 (9.09%)4/11 (36.3%)
S. Johannesburg3/24 1/3 (33.3%)3/3 (100%)
S. Virchow3/24
S. Typhimurium monofasic2/24 2/2 (100%)
S. Anatum2/24 1/2 (50%)
S. Vejle1/24
S. Salamae1/24
S. Agona1/24 1/1 (100%)
For each antibiotic, cells report number resistant/number tested (percentage); blank cells indicate no resistant isolates detected. Breakpoints were interpreted according to EUCAST 2024 [32]. MIC criteria using the Thermo Scientific™ Sensititre™ EUVSEC3 plate. Antibiotic classes are folate-pathway inhibitors (sulfamethoxazole, trimethoprim), polymyxins (colistin), quinolones (nalidixic acid, ciprofloxacin), tetracyclines (tetracycline), glycylcycline (tigecycline), carbapenems (meropenem), cephalosporins (cefotaxime, ceftazidime), penicillins (ampicillin), macrolides (azithromycin), amphenicols (chloramphenicol), and aminoglycosides (gentamicin). FQ: fluoroquinolones. n denotes the number of isolates per serotype.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Simó-Martínez, M.S.; Marco-Fuertes, A.; Galán-Relaño, Á.; Astorga Márquez, R.J.; Marin, C.; Valero Díaz, A.; Vega, S. Prevalence and Antimicrobial Resistance Patterns of Salmonella in Asymptomatic Horses in Eastern Spain: A One Health Perspective. Animals 2025, 15, 3413. https://doi.org/10.3390/ani15233413

AMA Style

Simó-Martínez MS, Marco-Fuertes A, Galán-Relaño Á, Astorga Márquez RJ, Marin C, Valero Díaz A, Vega S. Prevalence and Antimicrobial Resistance Patterns of Salmonella in Asymptomatic Horses in Eastern Spain: A One Health Perspective. Animals. 2025; 15(23):3413. https://doi.org/10.3390/ani15233413

Chicago/Turabian Style

Simó-Martínez, María Socorro, Ana Marco-Fuertes, Ángela Galán-Relaño, Rafael J. Astorga Márquez, Clara Marin, Antonio Valero Díaz, and Santiago Vega. 2025. "Prevalence and Antimicrobial Resistance Patterns of Salmonella in Asymptomatic Horses in Eastern Spain: A One Health Perspective" Animals 15, no. 23: 3413. https://doi.org/10.3390/ani15233413

APA Style

Simó-Martínez, M. S., Marco-Fuertes, A., Galán-Relaño, Á., Astorga Márquez, R. J., Marin, C., Valero Díaz, A., & Vega, S. (2025). Prevalence and Antimicrobial Resistance Patterns of Salmonella in Asymptomatic Horses in Eastern Spain: A One Health Perspective. Animals, 15(23), 3413. https://doi.org/10.3390/ani15233413

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop